|
|
| | 1H-Pyrrolizine-7a(5H)-methanol, 2-fluorotetrahydro-, (2R,7aR)- Basic information |
| Product Name: | 1H-Pyrrolizine-7a(5H)-methanol, 2-fluorotetrahydro-, (2R,7aR)- | | Synonyms: | 1H-Pyrrolizine-7a(5H)-methanol, 2-fluorotetrahydro-, (2R,7aR)-;((2R,7aR)-2-Fluorohexahydro-1H-pyrrolizin-7a-yl)methanol;[(2R,8R)-2-fluoro-1,2,3,5,6,7-hexahydropyrrolizin-8-yl]methanol;((2R,7aR)-2-Fluorotetrahydro-1H-pyrrolizin-7a(5H)-yl)methanol;(2R,7aR)-2-Fluorotetrahydro-1H-pyrrolizine-7a(5H)-methanol;[(2R,8R)-2-fluoro-1,2,3,5,6,7-hexahydropyrrolizin-8-yl]methanol - [F85894] | | CAS: | 2454490-66-3 | | MF: | C8H14FNO | | MW: | 159.2 | | EINECS: | | | Product Categories: | | | Mol File: | 2454490-66-3.mol |  |
| | 1H-Pyrrolizine-7a(5H)-methanol, 2-fluorotetrahydro-, (2R,7aR)- Chemical Properties |
| Boiling point | 225.6±15.0 °C(Predicted) | | density | 1.18±0.1 g/cm3(Predicted) | | storage temp. | Storage temp. 2-8°C | | pka | 15.81±0.10(Predicted) | | Appearance | Colorless to light yellow Liquid |
| | 1H-Pyrrolizine-7a(5H)-methanol, 2-fluorotetrahydro-, (2R,7aR)- Usage And Synthesis |
| Uses | Used as a pharmaceutical intermediate to prepare drugs for the prevention or treatment of KRAS G12D-related diseases. |
| | 1H-Pyrrolizine-7a(5H)-methanol, 2-fluorotetrahydro-, (2R,7aR)- Preparation Products And Raw materials |
|